TARA Protara Therapeutics Inc
Company Analysis
Latest News
🔴 Protara Therapeutics is trading 10.26% down in pre-market
Protara Therapeutics is trading at $3.50 (-10.26%), with no credible company-specific catalyst identified. - No credible August 21, 2026 company-specific...
🔴 Protara Therapeutics is trading 9.1% down today in pre-market with no clear catalyst identified
Protara Therapeutics is trading 9.1% down in pre-market at $3.60, with no credible company-specific announcement dated August 20, 2026, identified. - The...
🔴 Protara Therapeutics is trading 9.1% down today in pre-market with no clear company-specific catalyst
Protara Therapeutics is trading 9.1% down at $3.60 after closing at $3.96 on August 19, 2026; no credible company-specific announcement dated August 20 was...
🔴 Protara Therapeutics is trading 5.23% down today after Q2 loss exceeded expectations
Protara Therapeutics is trading 5.23% down now at $3.90 after reporting second-quarter results that missed analyst expectations. • Q2 loss was $21.7 million,...
Protara Therapeutics reports second quarter 2026 results and expects key clinical enrollment by year-end
Protara Therapeutics reported a second quarter 2026 net loss of $21.7 million, or $0.36 per share, as the company ramped up clinical activity for its lead...
Protara Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 10, 2026
Analysts expect Protara Therapeutics to report a Q2 2026 net loss of $0.33 per share on zero revenue, while the stock currently trades at $4.06, well below the...
🔴 Protara Therapeutics is trading 12.7% down today on no apparent news
Protara Therapeutics is trading 12.7% down at $3.50 in pre-market sessions despite a lack of fresh company-specific catalysts. • The sharp decline marks a...
🟢 Protara Therapeutics is trading 17.4% up today on light liquidity and speculative interest
Protara Therapeutics is trading 17.4% up at $4.60 in pre-market, jumping from its July 31 close of $3.92 on light liquidity and speculative interest. • There...
🟢 Protara Therapeutics is trading 9.7% up today with no clear news catalyst
Protara Therapeutics is trading at $4.30 (9.7%) up today in pre-market as the move appears driven by light liquidity rather than a clear news catalyst. • The...
🟢 Protara Therapeutics is trading 5.5% up today as risk appetite rebounds and small-cap biotechs recover
Protara Therapeutics is trading 5.5% up at $4.02 as it bounces from recent weakness and benefits from a broader risk-on move in U.S. equities. • The move...
🟢 Protara Therapeutics is trading 12.9% up today as it rebounds from recent weakness
Protara Therapeutics is trading at $4.30 (12.9%) up in pre-market, reversing several days of declines as broader market sentiment improves. • The jump appears...
🟢 Protara Therapeutics is trading 5.7% up today amid a broader risk-on market rally
Protara Therapeutics is trading 5.7% up today at $4.25 in pre-market, rebounding from a flat-to-slightly-negative week as U.S. equities experience a broader...
🔴 TARA is trading 5.3% down today amid a broader risk-off tone in equities
TARA is trading 5.3% down at $4.04 following a sharp pullback that appears driven by broader market sentiment rather than company-specific developments. • No...
🔴 TARA is trading 6.1% down today with no clear company-specific catalyst found
TARA is trading at $4.01 (-6.09%) in pre-market following a sharp overnight pullback despite a lack of company-specific news. • No earnings reports, FDA...
🟢 TARA makes sharp 10.0% jump
TARA is trading at $4.49, up 10.0% versus the comparison close of $4.08 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 TARA is trading 5.5% up today as it holds above $4.00 amid biotech sector momentum
TARA is trading at $4.30 (+5.51%) as the stock holds above key support levels amid broader biotech sector momentum. • The move follows a strong pre-market...
🟢 Protara Therapeutics Inc is trading 6.62% up in pre-market
TARA is trading at $4.35, up 6.62% in pre-market.
🟢 TARA is trading 5.1% up today following a JPMorgan price-target note and a rebound from the June 30 selloff
TARA is trading at $4.01 (+5.10%) as buyers step in following a JPMorgan price-target note and a technical rebound from the June 30 selloff. • The move...
Protara's Top Doctor Lasted Just 14 Months — Can a Tiny Biotech Keep Its Clinical Momentum Without a CMO?
Shares of Protara Therapeutics slid 7.7% to $3.84 on Monday as investors reacted to the sudden departure of Chief Medical Officer Leonardo Nicacio, who...
🔴 TARA is trading 7.7% down today following CMO resignation
TARA is trading 7.7% down at $3.84 following the announced resignation of its Chief Medical Officer, effective June 26, 2026. • The leadership change...